Pharmaceutical Industry Reports

Reports > Pharmaceutical > Selected Report

Global Paclitaxel Injection Market Report 2018

Single User: $3480
Multiple User: $5220
Enterprise User: $6960


Report Summary:

Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers.
Paclitaxel injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given once every 3 weeks. When paclitaxel injection manufactured with polyoxyethylated castor oil is used to treat Kaposis sarcoma, it may be given once every 2 or 3 weeks.


Scope of the Report:
This report focuses on the Paclitaxel Injection in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
In recent years, the growing population and increasing disease incidence of ovarian cancer, breast cancer and other cancers drive the global paclitaxel injection industry developing.

In the past five years from 2010-2014, global paclitaxel injection industry developed fast with a larger than 15% annual production growth rate. In China, due to the late start, the production growth rate is 12%~17%, which is a little lower than global average.

In the next few years, with the growing attention on women cancers from the whole society and much larger investment on R&D of paclitaxel injection, this industry will continue developing at a high speed. Whats more, because of the high gross profit of producing and selling paclitaxel injection, more and more investors will enter into this industry.

At present, the production of paclitaxel injection mainly concentrated in US, China and EU, the three regions produced about 77.30% of the global total products. Of those, US are the largest production region with a 42.69% of global production market share.

In the future, with the expanded capacity of paclitaxel injection, the manufacturers will face the high risk of price and gross margin decline.

The worldwide market for Paclitaxel Injection is expected to grow at a CAGR of roughly 11.0% over the next five years, will reach 3680 million US$ in 2023, from 2180 million US$ in 2017, according to a new GIR study.

Market Segment by Manufacturers, this report covers
Bristol-Myers Squibb
Celgene Corporation
Hospira
Biological E.
Taj Accura
Khandelwal Laboratories
Luye Pharma
Beijing Youcare
Beijing Union
Haiyao
Chuntch

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Drug Strength
Raw meterial Paclitaxel API source

Market Segment by Applications, can be divided into
Ovarian cancer
Breast cancer
Cervical cancer
Pancreatic cancer
Other

There are 15 Chapters to deeply display the global Paclitaxel Injection market.
Chapter 1, to describe Paclitaxel Injection Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Paclitaxel Injection, with sales, revenue, and price of Paclitaxel Injection, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Paclitaxel Injection, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Paclitaxel Injection market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Paclitaxel Injection sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents / Index:

Table of Contents

1 Market Overview
1.1 Paclitaxel Injection Introduction
1.2 Market Analysis by Type
1.2.1 Drug Strength
1.2.2 Raw meterial Paclitaxel API source
1.3 Market Analysis by Applications
1.3.1 Ovarian cancer
1.3.2 Breast cancer
1.3.3 Cervical cancer
1.3.4 Pancreatic cancer
1.3.5 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb
2.1.1 Business Overview
2.1.2 Paclitaxel Injection Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bristol-Myers Squibb Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Celgene Corporation
2.2.1 Business Overview
2.2.2 Paclitaxel Injection Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Celgene Corporation Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Hospira
2.3.1 Business Overview
2.3.2 Paclitaxel Injection Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Hospira Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Biological E.
2.4.1 Business Overview
2.4.2 Paclitaxel Injection Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Biological E. Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Taj Accura
2.5.1 Business Overview
2.5.2 Paclitaxel Injection Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Taj Accura Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Khandelwal Laboratories
2.6.1 Business Overview
2.6.2 Paclitaxel Injection Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Khandelwal Laboratories Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Luye Pharma
2.7.1 Business Overview
2.7.2 Paclitaxel Injection Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Luye Pharma Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Beijing Youcare
2.8.1 Business Overview
2.8.2 Paclitaxel Injection Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Beijing Youcare Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Beijing Union
2.9.1 Business Overview
2.9.2 Paclitaxel Injection Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Beijing Union Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Haiyao
2.10.1 Business Overview
2.10.2 Paclitaxel Injection Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Haiyao Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Chuntch
2.11.1 Business Overview
2.11.2 Paclitaxel Injection Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Chuntch Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Paclitaxel Injection Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Paclitaxel Injection Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Paclitaxel Injection Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Paclitaxel Injection Manufacturer Market Share in 2017
3.3.2 Top 6 Paclitaxel Injection Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Paclitaxel Injection Market Analysis by Regions
4.1 Global Paclitaxel Injection Sales, Revenue and Market Share by Regions
4.1.1 Global Paclitaxel Injection Sales and Market Share by Regions (2013-2018)
4.1.2 Global Paclitaxel Injection Revenue and Market Share by Regions (2013-2018)
4.2 North America Paclitaxel Injection Sales and Growth Rate (2013-2018)
4.3 Europe Paclitaxel Injection Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Paclitaxel Injection Sales and Growth Rate (2013-2018)
4.5 South America Paclitaxel Injection Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Paclitaxel Injection Sales and Growth Rate (2013-2018)
5 North America Paclitaxel Injection by Countries
5.1 North America Paclitaxel Injection Sales, Revenue and Market Share by Countries
5.1.1 North America Paclitaxel Injection Sales and Market Share by Countries (2013-2018)
5.1.2 North America Paclitaxel Injection Revenue and Market Share by Countries (2013-2018)
5.2 United States Paclitaxel Injection Sales and Growth Rate (2013-2018)
5.3 Canada Paclitaxel Injection Sales and Growth Rate (2013-2018)
5.4 Mexico Paclitaxel Injection Sales and Growth Rate (2013-2018)
6 Europe Paclitaxel Injection by Countries
6.1 Europe Paclitaxel Injection Sales, Revenue and Market Share by Countries
6.1.1 Europe Paclitaxel Injection Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Paclitaxel Injection Revenue and Market Share by Countries (2013-2018)
6.2 Germany Paclitaxel Injection Sales and Growth Rate (2013-2018)
6.3 UK Paclitaxel Injection Sales and Growth Rate (2013-2018)
6.4 France Paclitaxel Injection Sales and Growth Rate (2013-2018)
6.5 Russia Paclitaxel Injection Sales and Growth Rate (2013-2018)
6.6 Italy Paclitaxel Injection Sales and Growth Rate (2013-2018)
7 Asia-Pacific Paclitaxel Injection by Countries
7.1 Asia-Pacific Paclitaxel Injection Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Paclitaxel Injection Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Paclitaxel Injection Revenue and Market Share by Countries (2013-2018)
7.2 China Paclitaxel Injection Sales and Growth Rate (2013-2018)
7.3 Japan Paclitaxel Injection Sales and Growth Rate (2013-2018)
7.4 Korea Paclitaxel Injection Sales and Growth Rate (2013-2018)
7.5 India Paclitaxel Injection Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Paclitaxel Injection Sales and Growth Rate (2013-2018)
8 South America Paclitaxel Injection by Countries
8.1 South America Paclitaxel Injection Sales, Revenue and Market Share by Countries
8.1.1 South America Paclitaxel Injection Sales and Market Share by Countries (2013-2018)
8.1.2 South America Paclitaxel Injection Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Paclitaxel Injection Sales and Growth Rate (2013-2018)
8.3 Argentina Paclitaxel Injection Sales and Growth Rate (2013-2018)
8.4 Colombia Paclitaxel Injection Sales and Growth Rate (2013-2018)
9 Middle East and Africa Paclitaxel Injection by Countries
9.1 Middle East and Africa Paclitaxel Injection Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Paclitaxel Injection Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Paclitaxel Injection Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Paclitaxel Injection Sales and Growth Rate (2013-2018)
9.3 UAE Paclitaxel Injection Sales and Growth Rate (2013-2018)
9.4 Egypt Paclitaxel Injection Sales and Growth Rate (2013-2018)
9.5 Nigeria Paclitaxel Injection Sales and Growth Rate (2013-2018)
9.6 South Africa Paclitaxel Injection Sales and Growth Rate (2013-2018)
10 Global Paclitaxel Injection Market Segment by Type
10.1 Global Paclitaxel Injection Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Paclitaxel Injection Sales and Market Share by Type (2013-2018)
10.1.2 Global Paclitaxel Injection Revenue and Market Share by Type (2013-2018)
10.2 Drug Strength Sales Growth and Price
10.2.1 Global Drug Strength Sales Growth (2013-2018)
10.2.2 Global Drug Strength Price (2013-2018)
10.3 Raw meterial Paclitaxel API source Sales Growth and Price
10.3.1 Global Raw meterial Paclitaxel API source Sales Growth (2013-2018)
10.3.2 Global Raw meterial Paclitaxel API source Price (2013-2018)
11 Global Paclitaxel Injection Market Segment by Application
11.1 Global Paclitaxel Injection Sales Market Share by Application (2013-2018)
11.2 Ovarian cancer Sales Growth (2013-2018)
11.3 Breast cancer Sales Growth (2013-2018)
11.4 Cervical cancer Sales Growth (2013-2018)
11.5 Pancreatic cancer Sales Growth (2013-2018)
11.6 Other Sales Growth (2013-2018)
12 Paclitaxel Injection Market Forecast (2018-2023)
12.1 Global Paclitaxel Injection Sales, Revenue and Growth Rate (2018-2023)
12.2 Paclitaxel Injection Market Forecast by Regions (2018-2023)
12.2.1 North America Paclitaxel Injection Market Forecast (2018-2023)
12.2.2 Europe Paclitaxel Injection Market Forecast (2018-2023)
12.2.3 Asia-Pacific Paclitaxel Injection Market Forecast (2018-2023)
12.2.4 South America Paclitaxel Injection Market Forecast (2018-2023)
12.2.5 Middle East and Africa Paclitaxel Injection Market Forecast (2018-2023)
12.3 Paclitaxel Injection Market Forecast by Type (2018-2023)
12.3.1 Global Paclitaxel Injection Sales Forecast by Type (2018-2023)
12.3.2 Global Paclitaxel Injection Market Share Forecast by Type (2018-2023)
12.4 Paclitaxel Injection Market Forecast by Application (2018-2023)
12.4.1 Global Paclitaxel Injection Sales Forecast by Application (2018-2023)
12.4.2 Global Paclitaxel Injection Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 1 hour.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 40095

Category: 16

Published date: 2018-06-13 09:22:11

Number of Pages: 130

Publisher Name: GIR

Over all Rating: 89 % (Average of Ratings provided by clients)